Linked Life Data

3156026

Source:http://linkedlifedata.com/resource/pubmed/id/3156026

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1985-4-3
pubmed:abstractText
Spontaneous and selected variants of Serratia marcescens with resistance against chloramphenicol, cotrimoxazole, nalidixic acid, and pipemidic acid, revealed moderately reduced susceptibility for enoxacin and norfloxacin, and slightly diminished susceptibility for ciprofloxacin. Therefore, urinary tract infections due to S. marcescens strains showing this nonspecific resistance mechanism still might be amenable to judicious chemotherapy with these three novel bacterial DNA gyrase inhibitors, particularly ciprofloxacin.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0009-3157
pubmed:author
pubmed:issnType
Print
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
34-9
pubmed:dateRevised
2009-11-11
pubmed:meshHeading
pubmed:year
1985
pubmed:articleTitle
Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.
pubmed:publicationType
Journal Article, Comparative Study